Shenzhen Mindray Bio-Medical Electronics stated at the performance briefing that it is expected to continue steady growth in the second half of the year, with international markets outperforming domestic markets. Domestic equipment business revenue accounted for about 27% of the company's overall revenue in the second half of last year. The performance of this business in the second half of this year will depend to a large extent on the scale and pace of equipment updates. The company expects overseas markets to continue to grow rapidly in the second half and for a considerable period of time in the future, especially in developing countries and the European market. In addition, Shenzhen Mindray Bio-Medical Electronics stated that external expansion through mergers and acquisitions has always been one of the company's growth foundations, and in the future, it will continue to explore investment and acquisition opportunities in a strategic and active but paced manner.
迈瑞医疗：预计下半年海外市场依旧会保持快速增长的趋势
Shenzhen Mindray Bio-Medical Electronics: It is expected that the overseas market will continue to maintain a rapid growth trend in the second half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.